SCHEMBL11089418

SCHEMBL11089418

Cc1cccc(/C=C2\CCn3c2nc2ccc(Cl)cc2c3=O)c1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
RAB9A P51151 3/20 0.55
NPC1 O15118 2/20 0.55
POLB P06746 1/20 0.54
CYP1A2 P05177 2/20 0.52
CYP1A1 P04798 1/20 0.52
CYP1B1 Q16678 1/20 0.52
ALOX5 P09917 2/20 0.52
MAPT P10636 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11089422 1.00 MEN1 (0.67) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11090599 0.90 MEN1 (0.67) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11090598 0.90 MEN1 (0.67) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11088066 0.88 MEN1 (0.59) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11088062 0.88 MEN1 (0.59) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11085033 0.88 MEN1 (0.65) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11085030 0.88 MEN1 (0.65) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11090418 0.87 RAB9A (0.55) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11090414 0.87 RAB9A (0.55) MEN1KMT2ARAB9ANPC1POLB
SCHEMBL11089193 0.85 KMT2A (0.65) MEN1KMT2ARAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4428952-A Substituted pyrrolo[2,1-b]quinazolines and pyrido[2,1-b]quinazolines useful for the treatment of or the prevention of gastrointestinal ulcers FARMITALIA CARLO ERBA S.P.A. (IT) 1984-01-31 US disclosed